July 13, 2024
Inhalation Anesthesia

According to the latest report by IMARC Group “Inhalation Anesthesia Market Report: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, The global inhalation anesthesia market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026.

Inhalation anesthesia refers to the medication that is induced to maintain the general anesthesia and sedation level in the body during surgery. It does not accumulate in the body and helps prevent excessive dosage while promoting the normal functioning of the patient. Inhalation anesthetic agents with low pungency and non-irritant odor are widely used in hospitals and other ambulatory healthcare centers for patients with asthma or sensitive air passages.

Request for a free sample copy of this report: https://www.imarcgroup.com/inhalation-anesthesia-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Market Trends:

The global inhalation anesthesia market is primarily driven by the growing aging population, which is more susceptible to cardiovascular, neurological, respiratory and degenerative disorders. Besides this, the increasing number of surgical procedures has also led to an escalated demand for inhalation anesthesia, which has a lower risk of delirium and is cost-effective than intravenous anesthesia(IVA). Furthermore, the development of anesthesia recycling systems for extracting anesthetic compounds from hospital vents and operating rooms is also contributing to the market growth. Some of the other factors, such as the introduction of variants with enhanced compatibility and minimal side-effects, improvements in the healthcare sector and extensive research and development (R&D) activities, provide positive growth to the market.

Breakup by Product:

  • Desflurane
  • Sevoflurane
  • Isoflurane
  • Others

Breakup by Application:

  • Induction
  • Maintenance

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Abbvie Inc.
  • Baxter International Inc.
  • Fresenius SE & Co. KGaA
  • Halocarbon Products Corporation
  • Hikma Pharmaceuticals PLC
  • Lunan Pharmaceutical Group Co. Ltd
  • Merck KGaA
  • Piramal Enterprises Ltd.
  • Troikaa Pharmaceuticals Ltd.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/inhalation-anesthesia-market

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Leave a Reply

Your email address will not be published. Required fields are marked *